MD Mednax Inc

Price (delayed)

$10.03

Market cap

$843.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.73

Enterprise value

$1.47B

Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of ...

Highlights
The quick ratio has grown by 23% year-on-year
The debt has decreased by 2.2% YoY
The company's EPS has shrunk by 192% YoY and by 165% QoQ
The net income has dropped by 191% year-on-year and by 165% since the previous quarter

Key stats

What are the main financial stats of MD
Market
Shares outstanding
84.12M
Market cap
$843.75M
Enterprise value
$1.47B
Valuations
Price to book (P/B)
0.99
Price to sales (P/S)
0.41
EV/EBIT
N/A
EV/EBITDA
49.26
EV/Sales
0.74
Earnings
Revenue
$1.99B
EBIT
-$6.28M
EBITDA
$29.89M
Free cash flow
$104M
Per share
EPS
-$0.73
Free cash flow per share
$1.27
Book value per share
$10.1
Revenue per share
$24.27
TBVPS
$9.91
Balance sheet
Total assets
$2.22B
Total liabilities
$1.37B
Debt
$701.65M
Equity
$849.06M
Working capital
$94.51M
Liquidity
Debt to equity
0.83
Current ratio
1.24
Quick ratio
1.16
Net debt/EBITDA
21.03
Margins
EBITDA margin
1.5%
Gross margin
21.1%
Net margin
-3%
Operating margin
0.4%
Efficiency
Return on assets
-2.6%
Return on equity
-6.6%
Return on invested capital
-0.5%
Return on capital employed
-0.3%
Return on sales
-0.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
0.4%
1 week
7.27%
1 month
10.83%
1 year
-30.97%
YTD
7.85%
QTD
7.85%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$1.99B
Gross profit
$421.57M
Operating income
$7.32M
Net income
-$60.41M
Gross margin
21.1%
Net margin
-3%
The net income has dropped by 191% year-on-year and by 165% since the previous quarter
The net margin has plunged by 188% YoY and by 165% from the previous quarter
MD's operating income has dropped by 96% year-on-year and by 95% since the previous quarter
The operating margin has dropped by 95% year-on-year and by 95% since the previous quarter

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
P/E
N/A
P/B
0.99
P/S
0.41
EV/EBIT
N/A
EV/EBITDA
49.26
EV/Sales
0.74
The company's EPS has shrunk by 192% YoY and by 165% QoQ
The P/B is 45% below the 5-year quarterly average of 1.8 and 18% below the last 4 quarters average of 1.2
The equity is down by 12% QoQ and by 4.8% YoY
The stock's price to sales (P/S) is 59% less than its 5-year quarterly average of 1.0 and 18% less than its last 4 quarters average of 0.5

Efficiency

How efficient is Mednax business performance
The ROA has plunged by 193% YoY and by 165% from the previous quarter
MD's return on equity has dropped by 187% year-on-year and by 165% since the previous quarter
The ROIC has plunged by 105% YoY and by 104% from the previous quarter
The company's return on sales has shrunk by 105% YoY and by 104% QoQ

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 62% greater than the total liabilities
The company's current ratio rose by 24% YoY and by 3.3% QoQ
The quick ratio has grown by 23% year-on-year
The debt is 17% less than the equity
MD's debt to equity is up by 14% since the previous quarter and by 3.8% year-on-year
The equity is down by 12% QoQ and by 4.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.